Salota, Evangeline A.
HRN: 22-58-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/07/2023
02/13/2023
IV
2.25gm
Q6
Spontaneous Bacterial Peritonitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes